Infectious Diseases News and Research

RSS

New DNA-based Zika vaccine demonstrates safety and ability to elicit immune response

A new generation DNA-based Zika vaccine is the first to demonstrate both safety and the ability to elicit an immune response against Zika in humans, according to new research from the Perelman School of Medicine at the University of Pennsylvania, conducted in partnership with The Wistar Institute, Inovio Pharmaceuticals, and GeneOne Life Science, Inc.

5 Oct 2017

Light-activated nanoparticles can provide crucial boost in effectiveness for antibiotics

Light-activated nanoparticles, also known as quantum dots, can provide a crucial boost in effectiveness for antibiotic treatments used to combat drug-resistant superbugs such as E. coli and Salmonella, new University of Colorado Boulder research shows.

4 Oct 2017

Researchers awarded NIH grant to develop, test new drugs for treating Giardia infections

The microscopic parasite Giardia can be found within Idaho, every region of the U.S. and around the world. While Giardia is not considered fatal, anyone who has suffered from the diarrheal disease knows how uncomfortable it can be.

3 Oct 2017

Statin use linked to reduced risk of S aureus bloodstream infection

Users of statins, widely prescribed for prevention of cardiac disease, have a 27% lower risk of contracting a Staphylococcus aureus (S aureus) bloodstream infection outside of a hospital, according to a new study in Mayo Clinic Proceedings.

3 Oct 2017

GM mosquitoes can have altered microbiota that suppresses human malaria-causing parasites

WHAT: Using genetically modified (GM) mosquitoes to reduce or prevent the spread of infectious diseases is a new but rapidly expanding field of investigation.

30 Sep 2017

University of Hawaii researcher receives $6.3 million grant for trivalent Ebola vaccine development

University of Hawaii vaccine researcher Axel Lehrer, PhD, has received a nearly $6.3 million grant to test whether the Ebola vaccine formula he has developed will protect against two additional viruses in the same family.

28 Sep 2017

Novartis partners with UC Berkeley to pursue 'undruggable' disease targets

Novartis has joined forces with researchers from the University of California, Berkeley, to develop new technologies for the discovery of next-generation therapeutics, pursuing the vast number of disease targets in cancer and other illnesses that have eluded traditional small-molecule compounds and are considered "undruggable."

28 Sep 2017

Achieving treatment targets of National HIV/AIDS Strategy would prevent new infections and deaths

An analysis led by a team of Massachusetts General Hospital investigators shows that achieving the treatment targets of the National HIV/AIDS Strategy by 2020 not only would prevent hundreds of thousands of new infections and deaths but also would demonstrate excellent value.

28 Sep 2017

Northumbria researcher develops new, faster and safer way to diagnose Ebola virus

A new, faster and safer way of diagnosing the Ebola virus has been developed by an academic from Northumbria University, Newcastle.

28 Sep 2017

High-speed method generates mini-protein binders with potential to become new class of drugs

Scientists have created a high-speed method to generate thousands of different, small, stable proteins from scratch that can be custom-designed to bind to specific therapeutic targets.

27 Sep 2017

Columbia University receives $9.6 million NIH grant for ME/CFS research center

The National Institutes of Health has awarded a five-year $9.6 million grant to the Center for Infection and Immunity at Columbia University's Mailman School of Public Health to create the Center for Solutions for Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (CfS for ME/CFS), an inter-disciplinary, inter-institutional research group dedicated to understanding the biology of the disease in order to develop effective means to diagnose, treat and prevent it.

27 Sep 2017

Scientists gain insight into how Ebola virus uses the body's defenses to speed up infection

Scientists from The University of Texas Medical Branch at Galveston have gained new insight into how the Ebola virus uses the body's natural defenses to speed the rate of infection and unleash its lethal disease, according to a new report in mBio.

26 Sep 2017

Antibiotics reduce risk of recurrent staph infections in children, research shows

The overuse of antibiotics has left some doctors questioning whether to give such drugs to children diagnosed with uncomplicated staph infections. Such infections often occur on the skin and look like a pus-filled bug bite.

26 Sep 2017

Positive mood on the day of flu jab can increase its protective effect, research finds

New research by a team of health experts at the University of Nottingham has found evidence that being in a positive mood on the day of your flu jab can increase its protective effect.

26 Sep 2017

Study: Antibody neutralizes dengue and Zika virus in mice

Brazil and other areas hardest hit by the Zika virus – which can cause babies to be born with abnormally small heads – are also home to dengue virus, which is spread by the same mosquito species.

25 Sep 2017

New gel patch could speed up healing and minimize formation of scars

Scientists from Nanyang Technological University, Singapore have developed a new gel patch prototype that could speed up the healing of a skin wound while minimizing the formation of scars. The team unveiled the patch today as a proof-of-concept.

25 Sep 2017

“Super malaria” resistant to standard medications in South East Asia

The spread of a single multidrug resistant malaria parasite strain in Vietnam is cause for alarm say researchers.

25 Sep 2017

Study identifies two genes involved in invasive group A Streptococcus infections

Group A Streptococcus bacteria cause a variety of illnesses that range from mild nuisances like strep throat to life-threatening conditions including pneumonia, toxic shock syndrome and the flesh-eating disease formally known as necrotizing fasciitis.

22 Sep 2017

Triple-action antibody to be tested as HIV vaccine

Scientists from the National Institutes of Health (NIH) in collaboration with the pharmaceutical company Sanofi have engineered a three-pronged antibody that protected monkeys from two strains of Human Immunodeficiency Virus (HIV) better than the equivalent naturally occurring antibodies.

22 Sep 2017

Experts advise new measures to combat antimicrobial resistance

An expert panel was formed in the United States to advise the government on how to deal with the problem of antimicrobial resistance (AMR), a growing menace. This panel has now come up with a set of recommendations that could help reduce AMR in humans and animals. Recommendations include development of new vaccines against infections, development of better diagnostic tools to detect the infections early and also new therapies to handle the infections.

22 Sep 2017

Infectious Diseases News and Research

New DNA-based Zika vaccine demonstrates safety and ability to elicit immune response

Light-activated nanoparticles can provide crucial boost in effectiveness for antibiotics

Researchers awarded NIH grant to develop, test new drugs for treating Giardia infections

Statin use linked to reduced risk of S aureus bloodstream infection

GM mosquitoes can have altered microbiota that suppresses human malaria-causing parasites

University of Hawaii researcher receives $6.3 million grant for trivalent Ebola vaccine development

Novartis partners with UC Berkeley to pursue 'undruggable' disease targets

Achieving treatment targets of National HIV/AIDS Strategy would prevent new infections and deaths

Northumbria researcher develops new, faster and safer way to diagnose Ebola virus

High-speed method generates mini-protein binders with potential to become new class of drugs

Columbia University receives $9.6 million NIH grant for ME/CFS research center

Scientists gain insight into how Ebola virus uses the body's defenses to speed up infection

Antibiotics reduce risk of recurrent staph infections in children, research shows

Positive mood on the day of flu jab can increase its protective effect, research finds

Study: Antibody neutralizes dengue and Zika virus in mice

New gel patch could speed up healing and minimize formation of scars

“Super malaria” resistant to standard medications in South East Asia

Study identifies two genes involved in invasive group A Streptococcus infections

Triple-action antibody to be tested as HIV vaccine

Experts advise new measures to combat antimicrobial resistance

NGS for Infectious Disease Surveillance eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News